- Catalog ingredients or strategy
- Copper peptide 0.2% in the catalog
- Provider
- CoreAge Rx
- Finished-product status
- Provider-described compounded prescription
- Source date
- October 8, 2026
What is being prescribed?
The provider places Bounce Back among prescribed compounded creams and identifies copper peptide at 0.2%. The short catalog entry does not establish every ingredient in the base or provide a complete dispensing label. Confirm the preparation and its classification during consultation.[source]
What supports the claims?
This review did not verify a clinical trial of the exact Bounce Back formulation. A biological explanation involving peptides or skin repair does not, by itself, show a visible benefit from a particular cream. It should not be turned into a promise to restore collagen or reverse aging.[source]
The detail that changes the comparison
AAD recommends realistic expectations, sunscreen and moisturizer when selecting skin-care products. Ask what a targeted peptide cream would add to that routine and how any benefit would be assessed. A broad repair label is not a diagnosis.[source]
Questions for the consultation
We have not worn the product and cannot reliably describe texture, absorption, fragrance or irritation rates from firsthand experience. Ask about ingredients relevant to prior sensitivities and how to contact the clinician if the prescribed routine is uncomfortable.
Relevant alternatives
Confirm the current product price, quantity and renewal. If the primary concern is acne or pigmentation, compare the condition-focused choices rather than assuming a general firmness product covers every goal. The brand’s first position here is commercial and does not certify superior formulation quality.
Your questions, answered
Does the peptide percentage prove effectiveness?
No. Concentration is one formulation detail. It does not independently demonstrate that the finished product produces a clinically meaningful or visible result.
Was this cream tested by the publication?
No. This is a source-based review, without hands-on application, laboratory testing or independent medical review. Provider statements and broader ingredient evidence are identified separately.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- CoreAge Rx Help Center — What products does CoreAge Rx offer?Provider catalog, updated October 5, 2026; formulations and consultation terms
- American Academy of Dermatology — How to select anti-aging skin care productsSunscreen, moisturizers, realistic expectations and label claims
- FDA — Compounding and the FDA: Questions and AnswersCompounded drugs are not FDA-approved; oversight and evidence limitations